In one paragraphArticle in Physics in medicine and biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Isaac MeyerDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0002-7135-9489 Nils PetersDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0003-0860-5517 Giulia TamborinoDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0003-3832-3625 Hoyeon LeeDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0002-1165-1509 Alejandro BertoletDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0002-9890-693X Bruce FaddegonDepartment of Radiation Oncology, University of California San Francisco, San Francisco, United States of America.ORCID 0000-0002-4573-1582 Matthew M MilleDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, United States of America.ORCID 0000-0003-2529-1409 Choonsik LeeDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, United States of America.ORCID 0000-0002-6219-6622 Jan SchuemannDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0002-7554-8818 Harald PaganettiDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, United States of America.ORCID 0000-0002-6257-2413 Funding
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2021 to 2025
$14.0MThe TOPAS Tool for Particle Simulation, a Monte Carlo Simulation Tool for Physics, Biology and Clinical ResearchU24CA215123 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FADDEGON, BRUCE · 2018 to 2022
$4.2MNCI NIH HHS P01 CA261669NCI NIH HHS U24 CA215123
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Monte Carlo MethodRadiotherapy Planning, Computer-AssistedHumansNeoplasms, Radiation-InducedPhantoms, ImagingRadiotherapy DosageRisk Assessmentcomputational phantomsMonte Carlo dose calculationout-of-field dosesecond cancer risk
Identifiers
PMID39019051
PMCPMC11345907
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390